We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+16.02%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$3.09B
AUM Growth
+$972M
(+46%)
Cap. Flow
+$684M
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
6.41%
Holding
2,561
New
545
Increased
906
Reduced
750
Closed
342
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$27.9M |
| 2 |
Humana
HUM
|
+$18.6M |
| 3 |
CMS Energy
CMS
|
+$17.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$15M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$92M |
| 2 |
Microsoft
MSFT
|
+$10.4M |
| 3 |
RTX Corp
RTX
|
+$10.3M |
| 4 |
Synopsys
SNPS
|
+$10.3M |
| 5 |
Weyerhaeuser
WY
|
+$9.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.11% |
| 2 | Technology | 15.39% |
| 3 | Healthcare | 12.56% |
| 4 | Financials | 10.75% |
| 5 | Industrials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CRISPR Therapeutics
CRSP
$5.19B
| $85K | ﹤0.01% |
2,383
-37,167
| -94% | -$1.29M |
|
|
CSLT
2027
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $84K | ﹤0.01% |
+22,432
| New | +$71.2K |
|
2028
Helix Energy Solutions
HLX
$1.42B
| $83K | ﹤0.01% |
10,508
-34,554
| -77% | -$248K |
|
|
NOAH
2029
Noah Holdings
NOAH
$598M
| $83K | ﹤0.01% |
+1,705
| New | +$82.7K |
|
2030
Citizens
CIA
$206M
| $82K | ﹤0.01% |
12,289
-3,163
| -20% | -$22.6K |
|
2031
Guidewire Software
GWRE
$14.2B
| $82K | ﹤0.01% |
847
-924
| -52% | -$82.6K |
|
2032
Winnebago Industries
WGO
$903M
| $82K | ﹤0.01% |
2,644
-13,553
| -84% | -$407K |
|
|
NBRV
2033
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $82K | ﹤0.01% |
+134
| New | +$73.1K |
|
2034
Geron
GERN
$969M
| $81K | ﹤0.01% |
+48,707
| New | +$66.6K |
|
2035
Lennox International
LII
$15.3B
| $81K | ﹤0.01% |
306
-215
| -41% | -$51.4K |
|
2036
Federal Realty Investment Trust
FRT
$10.3B
| $80K | ﹤0.01% |
578
-2,229
| -79% | -$292K |
|
|
ARRY
2037
DELISTED
Array Biopharma Inc
ARRY
| $80K | ﹤0.01% |
3,281
-21,860
| -87% | -$455K |
|
2038
ICL Group
ICL
$6.87B
| $79K | ﹤0.01% |
15,048
+2,364
| +19% | +$13.1K |
|
2039
Valero Energy
VLO
$86.2B
| $79K | ﹤0.01% |
930
+30
| +3% | +$2.48K |
|
|
SSI
2040
DELISTED
Stage Stores Inc
SSI
| $79K | ﹤0.01% |
76,290
| – | – |
|
|
PETX
2041
DELISTED
Aratana Therapeutics, Inc.
PETX
| $79K | ﹤0.01% |
21,900
-3,700
| -14% | -$16K |
|
2042
Genesco
GCO
$426M
| $78K | ﹤0.01% |
+1,719
| New | +$78.8K |
|
2043
SIGA Technologies
SIGA
$222M
| $78K | ﹤0.01% |
12,955
-5,015
| -28% | -$33.7K |
|
|
TRST
2044
Trustco Bank Corp NY
TRST
$950M
| $78K | ﹤0.01% |
+2,016
| New | +$79.8K |
|
|
MRSN
2045
DELISTED
Mersana Therapeutics
MRSN
| $75K | ﹤0.01% |
570
+361
| +173% | +$45.4K |
|
|
KZR
2046
DELISTED
Kezar Life Sciences
KZR
| $74K | ﹤0.01% |
+418
| New | +$82.4K |
|
2047
United Microelectronic
UMC
$46.6B
| $74K | ﹤0.01% |
+39,547
| New | +$72.9K |
|
2048
Arlo Technologies
ARLO
$1.67B
| $73K | ﹤0.01% |
17,574
-6,031
| -26% | -$33.4K |
|
2049
Gran Tierra Energy
GTE
$316M
| $73K | ﹤0.01% |
+3,209
| New | +$75.3K |
|
2050
Xenon Pharmaceuticals
XENE
$6.13B
| $73K | ﹤0.01% |
7,160
+675
| +10% | +$5.72K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2019 Portfolio in Review
As of Q1 2019, Cubist Systematic Strategies held 2,561 positions worth $3.09B, up 46% from $2.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Cubist Systematic Strategies deployed $684M of net new capital in Q1 2019, opening 545 new positions and adding to 906 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92M trimmed.
- Cubist Systematic Strategies's largest Q1 2019 buy was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.
- Cubist Systematic Strategies added most to ConocoPhillips in Q1 2019, an estimated $27.9M increase.
- Cubist Systematic Strategies's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92M.
- Cubist Systematic Strategies fully exited Nasdaq in Q1 2019, selling an estimated $6.35M.
- Cubist Systematic Strategies's ten largest holdings make up 6.4% of its $3.09B portfolio in Q1 2019.
- Cubist Systematic Strategies opened 545 new positions and closed 342 in Q1 2019.
- Cubist Systematic Strategies's portfolio value rose 46% quarter-over-quarter to $3.09B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.